Paradigm Financial Partners, LLC Abb Vie Inc. Transaction History

Paradigm Financial Partners, LLC

$708 Million
Q3 2024

A detailed history of Paradigm Financial Partners, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Paradigm Financial Partners, LLC holds 9,233 shares of ABBV stock, worth $1.66 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

9,233

Previous 11,005 16.1%

Holding current value

$1.66 Million

Previous $1.89 Million 3.39%

% of portfolio

0.26%

Previous 0.29%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$163.84 - $199.33 $290,324 - $353,212	-1,772 Reduced 16.1%	9,233 $1.82 Million
Q2 2024 Aug 13, 2024	BUY	$154.79 - $180.76 $668,228 - $780,340	4,317 Added 64.55%	11,005 $1.89 Million
Q1 2024 May 15, 2024	SELL	$159.82 - $182.1 $20,616 - $23,490	-129 Reduced 1.89%	6,688 $1.22 Million
Q4 2023 Feb 05, 2024	BUY	$137.6 - $154.97 $16,512 - $18,596	120 Added 1.79%	6,817 $1.06 Million
Q3 2023 Oct 12, 2023	BUY	$133.59 - $154.65 $59,180 - $68,509	443 Added 7.08%	6,697 $998,000
Q2 2023 Jul 13, 2023	BUY	$132.51 - $164.9 $14,841 - $18,468	112 Added 1.82%	6,254 $842,000
Q1 2023 Apr 11, 2023	BUY	$144.61 - $166.54 $630,933 - $726,614	4,363 Added 245.25%	6,142 $978,000
Q4 2022 Jan 27, 2023	SELL	$138.31 - $165.87 $276 - $331	-2 Reduced 0.11%	1,779 $0
Q3 2022 Nov 09, 2022	SELL	$134.21 - $153.93 $30,063 - $34,480	-224 Reduced 11.17%	1,781 $250,000
Q2 2022 Jul 27, 2022	SELL	$137.62 - $174.96 $253,496 - $322,276	-1,842 Reduced 47.88%	2,005 $305,000
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $66,385 - $82,366	503 Added 15.04%	3,847 $650,000
Q4 2021 Feb 18, 2022	SELL	$107.43 - $135.93 $2.37 Million - $3 Million	-22,082 Reduced 86.85%	3,344 $453,000
Q4 2021 Feb 10, 2022	BUY	$107.43 - $135.93 $2.43 Million - $3.07 Million	22,581 Added 793.71%	25,426 $3.44 Million
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $11,597 - $13,165	109 Added 3.98%	2,845 $315,000
Q2 2021 Aug 12, 2021	BUY	$105.21 - $117.21 $287,854 - $320,686	2,736 New	2,736 $308,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Paradigm Financial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Paradigm Financial Partners, LLC with notifications on news.

Account

Paradigm Financial Partners, LLC Abb Vie Inc. Transaction History